Adakveo
Crizanlizumab · Novartis Pharmaceuticals Corporation
PRESCRIPTION ONLY (USA)Adakveo ingredients
| Active ingredient | Strength |
|---|---|
| Crizanlizumab | 10 mg/mL |
What Adakveo is used for
Adakveo is a specialist medicine (selectin blocker). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Adakveo
- Generic name
- Crizanlizumab
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Selectin Blocker
- FDA approval
- Biologic licence (BLA) BLA761128
- On the US market since
- 2019
Official information
- Adakveo prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Crizanlizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Adakveo?
Adakveo (Crizanlizumab) is a specialist medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Adakveo?
Adakveo contains Crizanlizumab (10 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA